Fair Isaac Corp. (FICO) Set to Announce Quarterly Earnings on Thursday

Share on StockTwits

Fair Isaac Corp. (NASDAQ:FICO) will announce its Q314 earnings results on Thursday, July 24th. Analysts expect the company to announce earnings of $0.68 per share and revenue of $190.90 million for the quarter. Fair Isaac Corp. has set its FY14 guidance at $3.46-3.56 EPS.Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Fair Isaac Corp. (NASDAQ:FICO) last released its earnings data on Thursday, April 24th. The company reported $0.81 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.61 by $0.20. The company had revenue of $185.46 million for the quarter, compared to the consensus estimate of $187.10 million. During the same quarter last year, the company posted $0.69 earnings per share. Fair Isaac Corp.’s revenue was up 3.4% compared to the same quarter last year. On average, analysts expect Fair Isaac Corp. to post $2.53 EPS for the current fiscal year and $3.25 EPS for the next fiscal year.

Shares of Fair Isaac Corp. (NASDAQ:FICO) opened at 63.03 on Wednesday. Fair Isaac Corp. has a 52-week low of $48.58 and a 52-week high of $65.62. The stock’s 50-day moving average is $61.5 and its 200-day moving average is $56.9. The company has a market cap of $2.160 billion and a P/E ratio of 26.05.

Fair Isaac Corporation (NASDAQ:FICO) provides products and services that enable businesses to automate, improve and connect decisions to enhance business performance.

Receive News & Ratings for Fair Isaac Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fair Isaac Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.

Latest News

Washington Real Estate Investment Trust Given Consensus Rating of “Hold” by Brokerages
Washington Real Estate Investment Trust Given Consensus Rating of “Hold” by Brokerages
Qunar Cayman Islands Receives Consensus Rating of “Buy” from Analysts
Qunar Cayman Islands Receives Consensus Rating of “Buy” from Analysts
Neurocrine Biosciences Given Average Rating of “Buy” by Brokerages
Neurocrine Biosciences Given Average Rating of “Buy” by Brokerages
Astoria Financial Corp Given Consensus Recommendation of “Hold” by Analysts
Astoria Financial Corp Given Consensus Recommendation of “Hold” by Analysts
KBR Receives Average Recommendation of “Buy” from Analysts
KBR Receives Average Recommendation of “Buy” from Analysts
Vanguard Natural Resources Given Consensus Recommendation of “Hold” by Analysts
Vanguard Natural Resources Given Consensus Recommendation of “Hold” by Analysts


Leave a Reply

 
Advertisement
Advertisement
© 2006-2014 Mideast Time.